Category: Syneron Medical Ltd.Syndicate content

Syneron names new CEO, beats The Street and buys New Star Lasers

February 24, 2014 by Arezu Sarvestani

Syneron Medical has a big week with Q4 earnings that beat estimates, a new chief executive and the $15 million acquisition of New Star Lasers and its CoolTouch aesthetic devices.

Syneron names new CEO, beats The Street and buys New Star Lasers

Israeli device maker Syneron Medical Ltd. (NSDQ:ELOS) made some major moves this month, announcing a new CEO alongside strong Q4 earnings and signing a deal to acquire New Lasers Inc.

Syneron, Iluminage land expanded indication on hair removal system

December 20, 2013 by Chris Walker

Iluminage Beauty, the Syneron Medical & Unilever Ventures joint venture, landed expanded indication from the FDA for its me brand of home-use hair removal systems.

Iluminage Beauty wins expanded indication on hair removal system

Iluminage Beauty, the joint venture between Unilever Ventures & Syneron Medical Ltd. (NSDQ:ELOS), won expanded indication from the FDA for its "me" brand of home-use hair removal products.

Cambridge Heart chairman, ex-CEO both resign | Personnel Moves

December 3, 2013 by Chris Walker

Ali Haghighi-Mood, the former president & CEO of Cambridge Heart, and chairman Roderick de Greef both resign for unnamed reasons.

fired/hired

Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.

Syneron, Unilever Ventures make joint venture Iluminage Beauty

November 13, 2013 by Chris Walker

Syneron and Unilever subsidiaries have established a joint venture for home beauty devices, causing Syneron shares to jump by around 16%, this week.

Syneron, Unilever Ventures make joint venture Iluminage Beauty

Syneron Medical Ltd. (NSDQ:ELOS) stock surged by 16% for the week after its subsidiary, Syneron Beauty, said it will partner with Unilever Ventures's Iluminage Inc., on a joint venture, to be called Iluminage Beauty.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Syneron lands 510(k), CE Mark for VelaShape III

September 16, 2013 by Brad Perriello

Syneron wins 510(k) clearance from the FDA and CE Mark approval in the European Union for its VelaShape III device.

Syneron lands 510(k), CE Mark for VelaShape III

Syneron Medical Ltd. (NSDQ:ELOS) said it won a pair of regulatory nods for its VelaShape III "body shaping" device.

Syneron takes a hit on Q2 stumble

August 15, 2013 by Sony Salzman

Syneron Medical's 2nd-quarter earnings meet Wall Street's expectations, but sales fall short, sending shares down on The Street.

Syneron takes a hit on Q2 stumble

Syneron Medical Ltd. (NSDQ:ELOS) stumbled during the 2nd quarter, posting earnings that were even with Wall Street's forecast but just missing sales expectations, sending share prices down this week.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Syneron lands Korean approval for skin-lightening product

August 14, 2013 by Sony Salzman

Israel-based cosmetics company Syneron lands approval in Korea for its Elure melanin-reducing product, a big win in the overall Asian market, which represents 95% of skin-lightening product sales.

Syneron logo

Israel-based aesthetic device company Syneron Medical (NSDQ:ELOS) landed Korean regulatory approval for its elure skin-lightening product, a victory the company touts as crucial in a high-demand market.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp